ID: ALA3577165

Max Phase: Preclinical

Molecular Formula: C21H42NO9P

Molecular Weight: 483.54

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)(O)O[C@@H](C)[C@H](N)C(=O)O

Standard InChI:  InChI=1S/C21H42NO9P/c1-3-4-5-6-7-8-9-10-11-12-13-14-19(24)29-15-18(23)16-30-32(27,28)31-17(2)20(22)21(25)26/h17-18,20,23H,3-16,22H2,1-2H3,(H,25,26)(H,27,28)/t17-,18+,20-/m0/s1

Standard InChI Key:  IPBQIUXFMHESEL-NSHGMRRFSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 483.54

Molecular Weight (Monoisotopic): 483.2597

AlogP: 3.53

#Rotatable Bonds: 21

Polar Surface Area: 165.61

Molecular Species: ZWITTERION

HBA: 8

HBD: 4

#RO5 Violations: 0

HBA (Lipinski): 10

HBD (Lipinski): 5

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 1.54

CX Basic pKa: 9.45

CX LogP: 2.20

CX LogD: -0.88

Aromatic Rings: 0

Heavy Atoms: 32

QED Weighted: 0.11

Np Likeness Score: 0.79

References

1. Ikubo M, Inoue A, Nakamura S, Jung S, Sayama M, Otani Y, Uwamizu A, Suzuki K, Kishi T, Shuto A, Ishiguro J, Okudaira M, Kano K, Makide K, Aoki J, Ohwada T..  (2015)  Structure-activity relationships of lysophosphatidylserine analogs as agonists of G-protein-coupled receptors GPR34, P2Y10, and GPR174.,  58  (10): [PMID:25970039] [10.1021/jm5020082]

Source

Source(1):

• Scientific Literature